StonvexLoading…
StonvexStonvexStonvexCore line items from CLNN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $484.00K | $376.00K | $107.00K | $473.00K |
Operating Income | $-30.61M | $-21.07M | $-10.73M | $-48.41M |
Net Income | $-39.33M | $-25.14M | $-11.77M | $-29.92M |
EPS (Diluted) | $-8.11 | $-9.11 | $-0.15 | $-0.46 |
Total Assets | $60.43M | $67.84M | $39.89M | $44.49M |
Total Liabilities | $39.03M | $46.31M | $41.52M | $41.26M |
Cash & Equivalents | $42.11M | $49.24M | $18.44M | $18.33M |
Free Cash Flow OCF − CapEx | $-23.29M | $-16.48M | $-9.50M | $-44.19M |
Shares Outstanding | 128.41M | 128.40M | 77.99M | 74.76M |